Product Code: ETC8846004 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Molecular breast imaging (MBI) is gaining traction in the Philippines as a supplementary diagnostic tool for detecting breast cancer, particularly in women with dense breast tissue. MBI offers higher sensitivity compared to traditional mammography, improving early cancer detection rates. The increasing prevalence of breast cancer, government initiatives for early screening, and technological advancements in imaging techniques are driving market growth.
The rising incidence of breast cancer and the increasing focus on early detection are key drivers of the molecular breast imaging (MBI) market in the Philippines. MBI offers higher sensitivity in detecting tumors, especially in women with dense breast tissue, making it a valuable diagnostic tool. Government initiatives promoting breast cancer screening, coupled with advancements in imaging technology, are further boosting market adoption. Additionally, increased healthcare awareness and accessibility to diagnostic centers are contributing to market expansion.
Molecular Breast Imaging (MBI) in the Philippines encounters challenges related to high equipment costs, lack of trained radiologists, and limited availability in rural areas. The preference for conventional mammography and ultrasound, due to affordability and accessibility, hampers the widespread use of MBI technology.
Breast cancer awareness and early detection initiatives in the Philippines are increasing demand for molecular breast imaging (MBI) solutions. Investment opportunities exist in developing advanced imaging technologies with high sensitivity and reduced radiation exposure. Companies focusing on AI-driven imaging, affordable screening, and partnerships with healthcare providers can benefit from this expanding market.
The government, through the DOH and the Philippine Health Insurance Corporation (PhilHealth), promotes early breast cancer detection by integrating molecular breast imaging (MBI) in public health programs. Policies ensure the affordability and accessibility of MBI procedures in government hospitals. Tax incentives encourage investment in advanced imaging technologies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Molecular Breast Imaging (MBI) Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Molecular Breast Imaging (MBI) Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Molecular Breast Imaging (MBI) Market - Industry Life Cycle |
3.4 Philippines Molecular Breast Imaging (MBI) Market - Porter's Five Forces |
3.5 Philippines Molecular Breast Imaging (MBI) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Philippines Molecular Breast Imaging (MBI) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Philippines Molecular Breast Imaging (MBI) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Molecular Breast Imaging (MBI) Market Trends |
6 Philippines Molecular Breast Imaging (MBI) Market, By Types |
6.1 Philippines Molecular Breast Imaging (MBI) Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Philippines Molecular Breast Imaging (MBI) Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Philippines Molecular Breast Imaging (MBI) Market Revenues & Volume, By Detection, 2021- 2031F |
6.1.4 Philippines Molecular Breast Imaging (MBI) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.5 Philippines Molecular Breast Imaging (MBI) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Philippines Molecular Breast Imaging (MBI) Market, By End users |
6.2.1 Overview and Analysis |
6.2.2 Philippines Molecular Breast Imaging (MBI) Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.2.3 Philippines Molecular Breast Imaging (MBI) Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.2.4 Philippines Molecular Breast Imaging (MBI) Market Revenues & Volume, By Ambulatotory Surgical Centers, 2021- 2031F |
6.2.5 Philippines Molecular Breast Imaging (MBI) Market Revenues & Volume, By Research Centers, 2021- 2031F |
7 Philippines Molecular Breast Imaging (MBI) Market Import-Export Trade Statistics |
7.1 Philippines Molecular Breast Imaging (MBI) Market Export to Major Countries |
7.2 Philippines Molecular Breast Imaging (MBI) Market Imports from Major Countries |
8 Philippines Molecular Breast Imaging (MBI) Market Key Performance Indicators |
9 Philippines Molecular Breast Imaging (MBI) Market - Opportunity Assessment |
9.1 Philippines Molecular Breast Imaging (MBI) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Philippines Molecular Breast Imaging (MBI) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Philippines Molecular Breast Imaging (MBI) Market - Competitive Landscape |
10.1 Philippines Molecular Breast Imaging (MBI) Market Revenue Share, By Companies, 2024 |
10.2 Philippines Molecular Breast Imaging (MBI) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |